Share on LinkedInShare on LinkedIn

ARTICLE · 29 MARCH 1995

Pharmaceuticals - Belgian Regulations on Publicity for Pharmaceuticals

BelgiumIntellectual Property

The Law of 25 March 1964 on medicinal products prohibits
  • (i) publicity regarding medicinal products which are not registered
  • or whose registrations have been suspended or withdrawn,
  • (ii) publicity aimed at the public (as opposed to practitioners)
  • regarding medicinal products which must be prescribed by
  • physicians and
  • (iii) publicity aimed at the public regarding medicinal products
  • treating certain diseases which are listed by Royal Decrees
  • (such as tuberculosis, poliomyelitis, cancer, diabetes or
  • sexually transmitted diseases).

Specific rules are implemented by the Royal Decree of 9 July 1984 regarding information and publicity on medicinal products. This Royal Decree has been modified several times mainly in order to incorporate European legislation. The latest European Directive 92/28/EC of 31 March 1992, of which most provisions are already embodied in the above Decree, has not yet been formerly incorporated into Belgian legislation.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from